TY - JOUR
KW - Analgesics, Opioid/adverse effects/therapeutic use
KW - Drug Overdose/drug therapy/epidemiology
KW - Drug Prescriptions
KW - Humans
KW - naloxone
KW - Naloxone/therapeutic use
KW - Narcotic Antagonists/therapeutic use
KW - opioid overdose
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Pharmacy
KW - policy
KW - Third-party prescribing
KW - United States/epidemiology
AU - P. R. Freeman
AU - E. R. Hankosky
AU - M. R. Lofwall
AU - J. C. Talbert
A1 - 
BT - Drug and alcohol dependence
C5 - Financing & Sustainability; Opioids & Substance Use
CY - Ireland
JF - Drug and alcohol dependence
PB - Elsevier B.V
PP - Ireland
PY - 2018
SN - 1879-0046; 0376-8716
SP - 361
EP - 364
EP - 
T1 - The changing landscape of naloxone availability in the United States, 2011 - 2017
T2 - Drug and alcohol dependence
TI - The changing landscape of naloxone availability in the United States, 2011 - 2017
U1 - Financing & Sustainability; Opioids & Substance Use
U2 - 30195192
VL - 191
VO - 1879-0046; 0376-8716
Y1 - 2018
ER -